WAUD CAPITAL PARTNERS other names

{{ Info.Overview }}
Revenue: {{ Info.Revenue | formatUSD }} Headquarters: {{ Info.Headquarters }}

Adviser Profile

As of Date:

04/16/2024

Adviser Type:

- Large advisory firm


Number of Employees:

70 -2.78%

of those in investment advisory functions:

65 -2.99%


Registration:

SEC, Approved, 3/29/2012

AUM:

4,561,699,151 -1.68%

of that, discretionary:

4,561,699,151 -1.68%

Private Fund GAV:

4,659,994,531 -1.66%

Avg Account Size:

198,334,746 -14.50%


SMA’s:

NO

Private Funds:

21 1

Contact Info

312 xxxxxxx

Websites :
Client Types:

+

Advisory Activities:

+

Compensation Arrangments:

+

Reported AUM

Discretionary
Non-discretionary
5B 4B 3B 3B 2B 1B 663M
2015 2016 2017 2018 2019 2020 2021 2022 2023

Recent News

Apotheco Appoints Veteran Healthcare and Pharmacy Leader as Chief Executive Officer
04/01/2021

Waud Capital Partners ("WCP"), an experienced private equity firm with a track record of successful investments in the pharmacy market, completed a majority investment in the Company to support ...

markets.businessinsider.com

Apotheco Appoints Veteran Healthcare and Pharmacy Leader as Chief Executive Officer
04/01/2021

Waud Capital Partners ("WCP"), an experienced private equity firm with a track record of successful investments in the pharmacy market, completed a majority investment in the Company to support ...

Morningstar

Apotheco Appoints Veteran Healthcare and Pharmacy Leader as Chief Executive Officer
04/01/2021

Waud Capital Partners ("WCP"), an experienced private equity firm with a track record of successful investments in the pharmacy market, completed a majority investment in the Company to support ...

prnewswire.com

Apotheco Appoints Veteran Healthcare and Pharmacy Leader as Chief Executive Officer
04/01/2021

Story continues Waud Capital Partners ("WCP"), an experienced private equity firm with a track record of successful investments in the pharmacy market, completed a majority investment in the ...

Yahoo Finance

Ivy Rehab Network Continues Rapid Growth, Partners with Mettler Center
03/31/2021

With the support of leading middle-market private equity firm Waud Capital Partners, Ivy Rehab will continue its strategic growth via the ongoing investment in new partners who embrace their ...

markets.businessinsider.com

Ivy Rehab Network Continues Rapid Growth, Partners with Mettler Center
03/31/2021

WHITE PLAINS, N.Y., March 31, 2021 /PRNewswire/ -- The Ivy Rehab Network ("Ivy"), a national leader in outpatient musculoskeletal rehabilitative services, has announced its partnership with the ...

prnewswire.com


Private Funds Structure

Fund Type Count GAV
Private Equity Fund 21 $4,659,994,531

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM # funds
A&M CAPITAL - - 5.2b - - - - 5.2b 6.2b 6
FALCON INVESTMENT ADVISORS, LLC - - 4.6b - - - - 4.6b 4.6b 8
LLR MANAGEMENT HOLDCO, L.P. - - 5.9b - - - - 5.9b 5.9b 17
KLINE HILL PARTNERS LP - - 5.0b - - - - 5.0b 5.0b 24
TRIVEST INVESTMENT ADVISORS, LLC - - 5.6b - - - - 5.6b 5.6b 14
GRANGER MANAGEMENT LLC - - 717.7m - - - - 717.7m 4.9b 8
MGG INVESTMENT GROUP LP - - 5.2b - - - - 5.2b 5.6b 33
57 STARS LLC - - 4.6b - - - - 4.6b 4.6b 15
NORWEST CAPITAL ADVISORS, LLC - - 4.2b - - - - 4.2b 4.2b 12
PACIFIC PRIVATE FUND ADVISORS LLC - - 3.7b - - - - 3.7b 5.7b 16

Private Funds



Employees




Brochure Summary

Overview

Firm Description Founded in 1993, Waud Capital Partners, L.L.C. (referred to herein as “WCP” or the “Firm”) and its related entities are a growth-oriented private equity investment firm based in Chicago that aims to acquire, improve and grow companies in the U.S. middle‐market primarily through control‐oriented equity investments. WCP partners with experienced management teams with the goal of building market leading companies within Healthcare and Software & Technology verticals and their intersection: companies that use technology to enable the delivery of traditional healthcare services and healthcare IT. WCP targets businesses in large, growing, inefficient and highly fragmented markets within these sectors and seeks to grow companies both organically and through follow-on acquisitions. WCP provides investment advisory services to the following private funds (collectively referred to herein as the “WCP Funds”): Waud Capital Partners III, L.P., Waud Capital Partners QP III, L.P. and Waud Capital Partners FIF III, L.P. (collectively, “Fund III”); Waud Capital Partners IV, L.P., Waud Capital Partners QP IV, L.P. and Waud Capital Partners FIF IV, L.P. (collectively, “Fund IV”); Waud Capital Partners QP V, L.P. and Waud Capital Partners FIF V, L.P. (collectively, “Fund V”); and Waud Capital Partners QP VI, L.P. and Waud Capital Partners FIF VI, L.P. (collectively, “Fund VI”). More information about the WCP Funds is available in WCP’s Form ADV Part 1, Schedule D, Section 7.B.(1). In addition to the WCP Funds, WCP also manages co-investment funds that facilitate co- investments in portfolio companies of the WCP Funds. WCP currently manages two types of co- investment funds: one type of co-investment fund includes certain WCP Fund limited partners or third-party investors investing in a single WCP portfolio company alongside a WCP Fund (“WCP Fund Co-Invest Funds”) and which is managed by the relevant WCP Fund general partner. The second type of co-investment fund includes only WCP senior management employees and WCP affiliated persons (i.e., no WCP Fund limited partners or third-party investors) investing on a side- by-side basis with the WCP Funds in the same portfolio companies as the relevant WCP Fund (“WCP Employee/Affiliate Co-Invest Funds” and together with the WCP Fund Co-Invest Funds, “WCP Co-Invest Funds”). Collectively, the WCP Funds, the WCP Fund Co-Invest Funds and Employee/Affiliate Co-Invest Funds are referred to in this Brochure as the “Funds”, unless the context otherwise requires. More information about the Funds is available in WCP’s Form ADV Part 1, Schedule D, Section 7.B.(1). Additionally, in certain circumstances, as more fully described in Item 7 below, WCP also permits certain limited partners and third parties to co-invest directly into a portfolio company. Unlike the Funds mentioned above, such direct co-investments are not considered clients of WCP. The Funds are private equity funds that invest through negotiated transactions in operating entities, generally referred to as “portfolio companies”, in the Healthcare and Software & Technology verticals and their intersection. Each portfolio company has its own management team responsible for managing its day-to-day operations, although the WCP senior investment professionals and other related persons of WCP and/or third-party persons appointed by WCP serve on such portfolio companies’ respective boards of directors or otherwise act to influence the management of portfolio companies held by the Funds. In addition, in some cases, WCP will more directly influence the day-to-day management of the portfolio company by recruiting and retaining certain individuals in various leadership roles, such as chief executive officer, chief operating officer, chief financial officer or in other roles. WCP’s investment advisory services to the Funds consist of identifying and evaluating investment opportunities, negotiating investments, managing and monitoring investments, and achieving dispositions for such investments. Investments are made predominantly
in non-public portfolio companies, although investments in public portfolio companies are permitted and on occasion, the Funds will own a public security position. WCP’s investment advisory services for the applicable Fund are governed by and detailed in the relevant private placement memoranda (each, “Private Placement Memorandum”), limited partnership agreements (each, “Partnership Agreement”), subscription agreements, side letters and investment management agreements (together with the Private Placement Memorandum and the Partnership Agreement, the “Governing Documents”) and investors determine the suitability of an investment in a Fund based on, among other things, the Governing Documents. WCP provides investment advisory services to the applicable Fund through its affiliated general partner entities (collectively, “WCP Fund GPs”), each of which is deemed registered under the Advisers Act pursuant to WCP’s registration in accordance with SEC guidance. The applicable WCP Fund GP retains investment discretion and limited partners in the Funds do not participate in the control or management of the Funds. While the WCP Fund GPs maintain ultimate authority over their respective Funds, WCP has been designated the role of investment adviser. This Brochure describes the business practices of the WCP Fund GPs, which operate as a single advisory business together with WCP, and unless the context otherwise requires, references in this Brochure to “WCP” should be construed to mean the relevant WCP Fund GP and/or Waud Capital Partners, L.L.C. and its personnel. More information about the WCP Fund GPs is available in WCP’s Form ADV Part 1, Schedule D, Section 7.A. Limited partners in a WCP Fund participate in the overall investment program for the applicable WCP Fund but under the relevant Governing Documents can be excused in certain circumstances from a particular investment due to legal, regulatory or other applicable constraints (however to date no such excuse has occurred). In addition, in accordance with industry common practice, WCP Fund GPs have entered into side letters or other similar agreements (“Side Letters”) with certain WCP Funds’ and WCP Fund Co-Invest Funds’ limited partners that have the effect of establishing rights under or supplementing the applicable Partnership Agreement. A WCP Fund GP reserves the right to enter into a Side Letter with certain limited partners of a Fund which provides such limited partners with different or preferential rights or terms, including, but not limited to, information rights, specialized reporting, priority co-investment rights or targeted co-investment amounts, rights to serve on a Fund’s Board of Advisors, transfer rights, confidentiality protections and disclosure rights, modification of default remedies, as well as economic, procedural and other terms. These rights, benefits or privileges are not always made available to all limited partners nor in some cases are they required to be disclosed to all limited partners. The Side Letter is negotiated at the time of the relevant limited partner’s capital commitment and once invested in a Fund, the limited partners generally cannot impose additional guidelines or restrictions on such Fund, consistent with general market practice. There can be no assurance that the side letter rights granted to one or more limited partners will not in certain cases disadvantage other limited partners. As of December 31, 2023, WCP managed regulatory assets under management of approximately $4.562 billion, all on a discretionary basis in WCP’s sole discretion. This calculation includes regulatory assets under management for all Funds. Principal Owners The WCP Fund GP entities are owned by Reeve B. Waud, his related entities and other WCP senior management employees. WCP is ultimately owned and controlled by Mr. Waud and entities under his control. For more information about WCP’s owners and executive officers, please see WCP’s Form ADV Part 1, Schedule A.